Disclosed herein are novel quinazolin-4-amine derivatives that are inhibitors of Clk1, Clk2, Clk3, Clk4, or Dyrk1A. Also disclosed are quinazolin-4-amine derivatives as potent and selective inhibitors of Clk1, Clk4, and Dyrk1A. These agents provide useful tools for the study of Clk1, Clk4 and Dyrk1A and their respective roles in pre-mRNA splicing. Methods of treating Clk1, Clk2, Clk4, or Dyrk1A kinase mediated disorders with certain quinazolin-4-amine derivatives are also disclosed.
本文公开了新型的
喹唑啉-4-胺衍
生物,它们是Clk1、Clk2、Clk3、Clk4或Dyrk1A的
抑制剂。还公开了
喹唑啉-4-胺衍
生物作为Clk1、Clk4和Dyrk1A的有效和选择性
抑制剂。这些药剂为研究Clk1、Clk4和Dyrk1A及其在前mRNA剪接中的作用提供了有用的工具。本文还公开了使用某些
喹唑啉-4-胺衍
生物治疗Clk1、Clk2、Clk4或Dyrk1A激酶介导的疾病的方法。